Zobrazeno 1 - 10
of 11
pro vyhledávání: '"C D Fegan"'
Autor:
C D Fegan
Publikováno v:
Eye. 16:98-106
Central retinal vein occlusion is one of the commonest vascular diseases of the eye. The pathogenesis is multifactorial with both local factors and systemic diseases being aetiologically important. Many thrombophilic conditions have recently been ide
Publikováno v:
British journal of haematology. 109(4)
We report two cases of acute myeloid leukaemia FAB classification M4Eo with high white cell counts at presentation, who developed acute respiratory failure with pulmonary infiltrates on chest radiograph soon after commencing conventional cytotoxic ch
Publikováno v:
British journal of haematology. 104(4)
In this longitudinal study we evaluated the clinical significance of screening for trisomy 12 by fluorescence in situ hybridization (FISH) and correlated these findings with survival, disease progression and need for treatment. Interphase FISH was pe
Publikováno v:
Hematological oncology. 16(2)
The success of peripheral blood progenitor cell (PBPC) transplantation depends upon harvesting adequate numbers of cells and accurate prediction of when to commence apheresis. Although peripheral white cell count (WBC) is commonly used to identify wh
Autor:
C D, Fegan
Publikováno v:
Hospital medicine (London, England : 1998). 59(2)
Tinzaparin is a low molecular weight heparin which is given subcutaneously once daily without the need for laboratory monitoring. Already established as effective therapy for deep venous thrombosis, in November 1997 it became the first low molecular
Autor:
L, Su'ut, S J, O'Connor, S J, Richards, R A, Jones, B E, Roberts, F E, Davies, C D, Fegan, A S, Jack, G J, Morgan
Publikováno v:
British journal of haematology. 101(1)
In order to delineate the specific morphological and immunophenotypic features of B-cell lymphoproliferative disorders associated with trisomy 12, 172 sequential unselected cases of CD19+CD5+ B-cell disorders, primarily affecting the peripheral blood
Publikováno v:
British journal of haematology. 93(2)
Publikováno v:
Clinical and laboratory haematology. 17(2)
Marked elevation of serum erythropoietin (sEPO) occurs following high dose chemotherapy for malignant disease. It has been proposed that the subsequent fall in sEPO constitutes a relative erythropoietin (EPO) deficiency, prompting trials of recombina
Publikováno v:
Journal of Antimicrobial Chemotherapy. 43:435-436